Evidence map›Paper›PMID 38483612›Full record

ArticleVirchows Archiv : an international journal of pathology2024

The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.

Naoki Takeda, Naohiro Makise, Hajime Kageyama, Tsukasa Takahashi, Hiroshi Katoh, Akiko Odaka, Mariko Oikawa, Takahiro Sugiyama, Hidetada Kawana, Akinobu Araki and 5 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Naoki TakedaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.ORCID http://orcid.org/0009-0008-2362-7179
Naohiro MakiseDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan. makise58@gmail.com.ORCID http://orcid.org/0000-0002-6991-747X
Hajime KageyamaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Tsukasa TakahashiDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Hiroshi KatohDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Akiko OdakaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Mariko OikawaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Takahiro SugiyamaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Hidetada KawanaDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Akinobu ArakiDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Hideyuki KinoshitaDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Yoko HagiwaraDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Hiroto KamodaDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Tsukasa YonemotoDivision of Orthopaedic Surgery, Chiba Cancer Center, Chiba, Japan.
Makiko ItamiDivision of Surgical Pathology, Chiba Cancer Center, 666-2 Nitona-Cho, Chuo-Ku, Chiba-Shi, Chiba, 260-8717, Japan.
Chiba Cancer Center · JP

Funding

JSPS KAKENHI JP23K06438
6 · The paper itself

Abstract

EWSR1::NFATC2 sarcoma, a rare round cell sarcoma constituting the majority of EWSR1::non-ETS sarcomas, has recently been defined in the latest WHO classification. To date, the cytological findings of EWSR1::NFATC2 sarcoma remain undocumented. We present the case of a 25-year-old man with a history of polyostotic fibrous dysplasia in the right leg, referred to our hospital with left thigh pain. Cytological findings included metachromasia, minimally pleomorphic round cells, and eosinophilic infiltration. There was no precursor fibrous dysplasia and the initial diagnosis was undifferentiated pleomorphic sarcoma. Following histologic review, we successfully performed immunocytochemistry and fluorescence in situ hybridization (FISH) on archival cytology specimens. The tumor cells were positive for NKX2-2, NKX3-1, and PAX7 and showed amplified 5' single signals of EWSR1 gene. Reverse transcriptase-polymerase chain reaction revealed an in-frame fusion of EWSR1 and NFATC2. This report describes the cytological features of EWSR1::NFATC2 sarcoma and highlights the diagnostic utility of archival cytology specimens.

Indexed as

Oncogene Proteins, FusionSarcomaAdultCytodiagnosisDiagnosis, DifferentialHumansIn Situ Hybridization, FluorescenceMaleNFATC Transcription FactorsRNA-Binding Protein EWSTranscription FactorsEWSR1 protein, humanNFATc2-EWSR1 fusion protein, humanNFATC2 protein, humanNFATC Transcription FactorsOncogene Proteins, FusionRNA-Binding Protein EWSTranscription FactorsCytologyEosinophilEWSR1::NFATC2 sarcomaFISHImmunocytochemistryMetachromasia

Identifiers

PMID38483612
OpenAlexW4392804859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.